Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 16, 2021; 9(32): 9847-9856
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9847
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9847
Treatment | All (n = 33) | Diet (n = 30) | Probiotics (n = 21) | Loperamide (n = 14) | Bismuth (n = 6) | Antibiotics (n = 9) | Mebeverine (n = 6) | 5-ASA (n = 5) | ||||||||
Data | P value | Data | P value | Data | P value | Data | P value | Data | P value | Data | P value | Data | P value | Data | P value | |
Mean BM | 0.003a | 0.003a | 0.007a | 0.027a | 0.18 | 0.042a | 0.1 | 0.066 | ||||||||
Before treatment | 10.3 ± 4.3 | 10.5 ± 4.4 | 10.2 ± 3.8 | 9.4 ± 3.2 | 9.0 ± 3.3 | 9.7 ± 5.1 | 11.8 ± 5.4 | 11.2 ± 5.01 | ||||||||
After treatment | 9.3 ± 4.1 | 9.3 ± 4.2 | 8.8 ± 3.2 | 8.14 ± 2.47 | 8.3 ± 2.4 | 7.6 ± 3.4 | 10.0 ± 5.3 | 8.6 ± 3.9 | ||||||||
Patients with bloody stools | 0.62 | 1 | 0.5 | 1 | 1 | 1 | 1 | 1 | ||||||||
Before treatment | 3 (9.1) | 3 (10) | 2 (9.5) | 1 (7.1) | 0 | 1 (11.1) | 1 (16.67) | 1 (20) | ||||||||
After treatment | 2 (6.06) | 2 (6.67) | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Patients with abdominal pain | 0.016a | 0.016a | 0.12 | 0.25 | 1 | 0.5 | 0.5 | 1 | ||||||||
Before treatment | 16 (48.4) | 13 (43.3) | 11 (52.3) | 7 (50) | 4 (66.6) | 4 (44.4) | 4 (66.7) | 2 (40) | ||||||||
After treatment | 9 (27.2) | 6 (20) | 7 (33.3) | 4 (28.5) | 3 (50) | 2 (22.2) | 2 (33.3) | 1 (20) | ||||||||
Mean clinical PDAI | 0.004a | 0.004a | 0.01a | 0.024a | 0.15 | 0.066 | 0.1 | 0.1 | ||||||||
Before treatment | 1.3 ± 1.1 | 1.3 ± 1.2 | 1.38 ± 1.11 | 1.5 ± 1.28 | 1.5 ± 1.2 | 1.67 ± 1.2 | 1.83 ± 1.32 | 2.2 ± 0.8 | ||||||||
After treatment | 0.87 ± 0.89 | 0.86 ± 0.93 | 0.80 ± 0.74 | 0.85 ± 0.77 | 1.1 ± 0.75 | 0.8 ± 0.7 | 0.83 ± 0.75 | 1.0 ± 1.0 | ||||||||
Mean endoscopic PDAI | 0.86 | 0.79 | 0.95 | 0.059 | 0.31 | 0.19 | 0.41 | 0.45 | ||||||||
Before treatment | 0.65 ± 0.97 | 0.65 ± 1.0 | 0.80 ± 1.12 | 0.57 ± 1.08 | 0 | 1.3 ± 1.2 | 0.83 ± 1.16 | 1.6 ± 1.5 | ||||||||
After treatment | 0.6 ± 1.1 | 0.66 ± 1.15 | 0.80 ± 1.32 | 0.92 ± 1.26 | 0.16 ± 0.40 | 1.7 ± 1.5 | 1.16 ± 1.16 | 2.2 ± 1.7 | ||||||||
Mean histologic PDAI | 0.60 | 0.66 | 0.77 | 0.31 | 1 | 0.1 | 0.7 | 0.7 | ||||||||
Before treatment | 0.76 ± 1.0 | 0.68 ± 1.04 | 0.83 ± 1.04 | 0.5 ± 0.84 | 0.16 ± 0.40 | 1.0 ± 1.06 | 1.16 ± 0.98 | 1.6 ± 1.3 | ||||||||
After treatment | 0.46 ± 0.76 | 0.51 ± 0.78 | 0.55 ± 0.82 | 0.64 ± 0.92 | 0.16 ± 0.40 | 1.1 ± 0.99 | 1.0 ± 1.2 | 1.0 ± 0.8 | ||||||||
Mean overall PDAI | 0.01a | 0.04a | 0.032a | 1 | 0.56 | 0.48 | 0.059 | 0.25 | ||||||||
Before treatment | 2.51 ± 2.38 | 2.46 ± 2.48 | 2.9 ± 2.54 | 2.42 ± 2.44 | 1.67 ± 1.2 | 3.8 ± 2.6 | 3.83 ± 2.78 | 5.4 ± 2.7 | ||||||||
After treatment | 1.93 ± 2.01 | 2.03 ± 2.09 | 2.1 ± 2.2 | 2.42 ± 2.37 | 1.50 ± 1.04 | 3.6 ± 2.6 | 3.0 ± 2.6 | 4.0 ± 2.9 |
- Citation: Gilad O, Rosner G, Brazowski E, Kariv R, Gluck N, Strul H. Management of pouch related symptoms in patients who underwent ileal pouch anal anastomosis surgery for adenomatous polyposis. World J Clin Cases 2021; 9(32): 9847-9856
- URL: https://www.wjgnet.com/2307-8960/full/v9/i32/9847.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i32.9847